451 related articles for article (PubMed ID: 29235051)
21. Molecular Screening for Cancer Treatment Optimization (MOSCATO-01) in Pediatric Patients: A Single-Institutional Prospective Molecular Stratification Trial.
Harttrampf AC; Lacroix L; Deloger M; Deschamps F; Puget S; Auger N; Vielh P; Varlet P; Balogh Z; Abbou S; Allorant A; Valteau-Couanet D; Sarnacki S; Gamiche-Rolland L; Meurice G; Minard-Colin V; Grill J; Brugieres L; Dufour C; Gaspar N; Michiels S; Vassal G; Soria JC; Geoerger B
Clin Cancer Res; 2017 Oct; 23(20):6101-6112. PubMed ID: 28733441
[No Abstract] [Full Text] [Related]
22. A clinical pharmacy pilot within a Precision Medicine Program for cancer patients and review of related pharmacist clinical practice.
Arnall JR; Petro R; Patel JN; Kennedy L
J Oncol Pharm Pract; 2019 Jan; 25(1):179-186. PubMed ID: 29078708
[TBL] [Abstract][Full Text] [Related]
23. Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.
Schmidt KT; Chau CH; Price DK; Figg WD
J Clin Pharmacol; 2016 Dec; 56(12):1484-1499. PubMed ID: 27197880
[TBL] [Abstract][Full Text] [Related]
24. Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.
Papademetriou IT; Porter T
Ther Deliv; 2015; 6(8):989-1016. PubMed ID: 26488496
[TBL] [Abstract][Full Text] [Related]
25. War and peace? The oncologic and the palliative care perspective on personalized cancer treatment in a patient with advanced cancer.
Masel EK; Schur S; Posch D; Weixler D; Meran JG; Schmidinger M; Watzke HH
Wien Klin Wochenschr; 2015 Aug; 127(15-16):635-8. PubMed ID: 25986998
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular Targets.
Moreira A; Masliah-Planchon J; Callens C; Vacher S; Lecerf C; Frelaut M; Borcoman E; Torossian N; Ricci F; Hescot S; Sablin MP; Tresca P; Loirat D; Melaabi S; Trabelsi-Grati O; Pierron G; Gentien D; Bernard V; Vincent Salomon A; Servant N; Bieche I; Le Tourneau C; Kamal M
Eur J Cancer; 2019 Nov; 121():202-209. PubMed ID: 31593830
[TBL] [Abstract][Full Text] [Related]
27. Real-world performance analysis of a novel computational method in the precision oncology of pediatric tumors.
Vodicska B; Déri J; Tihanyi D; Várkondi E; Kispéter E; Dóczi R; Lakatos D; Dirner A; Vidermann M; Filotás P; Szalkai-Dénes R; Szegedi I; Bartyik K; Gábor KM; Simon R; Hauser P; Péter G; Kiss C; Garami M; Peták I
World J Pediatr; 2023 Oct; 19(10):992-1008. PubMed ID: 36914906
[TBL] [Abstract][Full Text] [Related]
28. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
[TBL] [Abstract][Full Text] [Related]
29. [Interdisciplinary neuro-oncology: part 2: systemic therapy of primary brain tumors].
Tabatabai G; Hattingen E; Schlegel J; Stummer W; Schlegel U
Nervenarzt; 2014 Aug; 85(8):976-81. PubMed ID: 25037494
[TBL] [Abstract][Full Text] [Related]
30. Precision Oncology in Pediatric Cancer Surgery.
Lee WG; Kim ES
Surg Oncol Clin N Am; 2024 Apr; 33(2):409-446. PubMed ID: 38401917
[TBL] [Abstract][Full Text] [Related]
31. Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendations.
Miklja Z; Pasternak A; Stallard S; Nicolaides T; Kline-Nunnally C; Cole B; Beroukhim R; Bandopadhayay P; Chi S; Ramkissoon SH; Mullan B; Bruzek AK; Gauthier A; Garcia T; Atchison C; Marini B; Fouladi M; Parsons DW; Leary S; Mueller S; Ligon KL; Koschmann C
Neuro Oncol; 2019 Aug; 21(8):968-980. PubMed ID: 30805642
[TBL] [Abstract][Full Text] [Related]
32. Response Assessment in Neuro-Oncology Clinical Trials.
Wen PY; Chang SM; Van den Bent MJ; Vogelbaum MA; Macdonald DR; Lee EQ
J Clin Oncol; 2017 Jul; 35(21):2439-2449. PubMed ID: 28640707
[TBL] [Abstract][Full Text] [Related]
33. The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies.
Patterson SE; Liu R; Statz CM; Durkin D; Lakshminarayana A; Mockus SM
Hum Genomics; 2016 Jan; 10():4. PubMed ID: 26772741
[TBL] [Abstract][Full Text] [Related]
34. Update on the therapeutic approaches to brain tumors.
Lallana EC; Abrey LE
Expert Rev Anticancer Ther; 2003 Oct; 3(5):655-70. PubMed ID: 14599089
[TBL] [Abstract][Full Text] [Related]
35. Clinical Outcomes of Molecular Tumor Boards: A Systematic Review.
Larson KL; Huang B; Weiss HL; Hull P; Westgate PM; Miller RW; Arnold SM; Kolesar JM
JCO Precis Oncol; 2021 Jul; 5():. PubMed ID: 34632252
[TBL] [Abstract][Full Text] [Related]
36. A method to predict different mechanisms for blood-brain barrier permeability of CNS activity compounds in Chinese herbs using support vector machine.
Jiang L; Chen J; He Y; Zhang Y; Li G
J Bioinform Comput Biol; 2016 Feb; 14(1):1650005. PubMed ID: 26632324
[TBL] [Abstract][Full Text] [Related]
37. Adolescents and young adults with brain tumors in the context of molecular advances in neuro-oncology.
Zapotocky M; Ramaswamy V; Lassaletta A; Bouffet E
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 29049858
[TBL] [Abstract][Full Text] [Related]
38. Improving drug delivery to primary and metastatic brain tumors: strategies to overcome the blood-brain barrier.
Parrish KE; Sarkaria JN; Elmquist WF
Clin Pharmacol Ther; 2015 Apr; 97(4):336-46. PubMed ID: 25669487
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy in pediatric brain tumor and the challenge of the blood-brain barrier.
Malik JR; Podany AT; Khan P; Shaffer CL; Siddiqui JA; Baranowska-Kortylewicz J; Le J; Fletcher CV; Ether SA; Avedissian SN
Cancer Med; 2023 Dec; 12(23):21075-21096. PubMed ID: 37997517
[TBL] [Abstract][Full Text] [Related]
40. Community-driven development of a modified progression-free survival ratio for precision oncology.
Mock A; Heilig CE; Kreutzfeldt S; Huebschmann D; Heining C; Schröck E; Brors B; Stenzinger A; Jäger D; Schlenk R; Glimm H; Fröhling S; Horak P;
ESMO Open; 2019; 4(6):e000583. PubMed ID: 31798980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
